Matinas BioPharma Holdings, Inc. — Form D

Matinas BioPharma Holdings, Inc. of BEDMINSTER, NJ, a company, filed a Form D exempt-offering notice with the SEC on 2025-02-19. The offering totals $3.3M, of which $1.6M was reported sold. Industry: Biotechnology.

Offering

Issuer

Officers, directors & promoters (23)

NameRoleLocation
Evelyn D'AnDirectorBEDMINSTER, NJ
Eric EndeDirectorBEDMINSTER, NJ
Natasha GiordanoDirectorHoboken, NJ
Jerome JabbourDirectorBEDMINSTER, NJ
Robin SmithDirectorBEDMINSTER, NJ
Matthew WiklerDirectorBEDMINSTER, NJ
Jerome JabbourExecutive OfficerBEDMINSTER, NJ
Keith KucinskiExecutive OfficerBEDMINSTER, NJ
Roelof RongenDirectorDelray Beach, FL
Roelof RongenExecutive OfficerDelray Beach, FL
Abdel A FawzyExecutive OfficerBedminster, NJ
James F ScibettaDirectorBedminster, NJ
Jerome A JabbourDirectorBedminster, NJ
Jerome A JabbourExecutive OfficerBedminster, NJ
Douglas F KlingExecutive OfficerBedminster, NJ
Stefano A FerrariDirectorBedminster, NJ
Herbert A ConradDirectorBedminster, NJ
Adam A SternDirectorBedminster, NJ
Gary A GaglioneExecutive OfficerBedminster, NJ
George BobotasExecutive OfficerBedminster, NJ
STEPHEN P HARRINGTONDirectorPLYMOUTH MEETING, PA
STEPHEN P HARRINGTONExecutive OfficerPLYMOUTH MEETING, PA
Raphael J ManninoExecutive OfficerTampa, FL

Other filings by this issuer (5)

FiledFormOfferingSold
2017-01-26D$15.5M$15.5M
2016-08-12D$8.0M$4.4M
2015-04-13D$10.0M$10.0M
2013-08-07D$15.0M$7.6M
2013-07-25D$385K$385K

More